335 patients were recruited having TNBC or BRCA1/2 +ve metastatic BC and were divided into three groups: patients with germline BRCA mutation, patients with BRCA-like mutation in HR-genes and non-BRCA-like mutation [79]. Here, BRCA1 is linked to breast cancer.